Screening of blood donors for human cytomegalovirus (HCMV) IgG antibody with an enzyme immunoassay using recombinant antigens

Journal of Clinical Virology

Volumn 14, Issue 3, 1999, Pages 173-181

  Weber, Bernard ^a,b   Bargane Fall, El Hadji M ^a   Berger, Annemarie ^b   Doerr, Hans Wilhelm ^b  

^a Laboratoires Reunis Kutter Lieners Hastert Centre Langwies   (Luxembourg)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Delayed early DNA binding protein p52; HCMV tegument pp150; pp65 antigen; Recombinant antigens; Virus isolation

Indexed keywords

CYTOMEGALOVIRUS ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; VIRUS ANTIGEN;

ARTICLE; BLOOD DONOR; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOBLOTTING; INTERMETHOD COMPARISON; LABORATORY DIAGNOSIS; PRIORITY JOURNAL; SCREENING; SEROCONVERSION; VIRUS DETECTION; VIRUS ISOLATION;

ANTIBODIES, VIRAL; ANTIGENS, VIRAL; BLOOD DONORS; BLOTTING, WESTERN; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MASS SCREENING; PHOSPHOPROTEINS; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY; VIRAL MATRIX PROTEINS;

EID: 0032743972     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6532(99)00060-8     Document Type: Article

References (19)

1. Bünung H., Trenkler G. Nicht-parametrierbare Methoden. 1978;Springer Verlag, Berlin, Heidelberg, New York.
2. Doerr H.W., Albert S. New developments in CMV antibody screening. Biotest. Bull. 4:1990;125-130.
3. Doerr H.W., Rentschler M., Scheifler G. Serologic detection of active infections with human herpes viruses (CMV, EBV, HSV, VZV): diagnostic potential of IgA class and IgG subclass-specific antibodies. Infection. 15:1986;93-98.
4. Fischer L., Rautenberg P., Bienengraber H., Leimenstoll J. Antigenemia, immunoblotting and enzyme immunoassay for early diagnosis of cytomegalovirus infection in renal transplant recipients. Transpl. Int. 6:1993;201-205.
5. Hertenstein B., Hampl W., Bunjes D., Wiesneth M., Duncker C., Koszinowski U., Heimpel H., Arnold R., Mertens T.H. In vivo/ex vivo T cell depletion for GVHD prophylaxis influences onset and course of active cytomegalovirus infection and disease after BMT. Bone. Marrow. Transpl. 15:1995;387-393.
6. Landini M.P., Lazzarotto T., Ertl P.F. Humoral immune response to human cytomegalovirus DNA polymerase. J. Clin. Microbiol. 31:1993;724-726.
7. Landini M.P., Lazzarotto T., Ripalti A., Guan M.X., LaPlaca M. Antibody response to recombinant lambda gt11 fusion proteins in cytomegalovirus infection. J. Clin. Microbiol. 27:1989;2324-2327.
8. Lazzarotto T., Casa B.D., Campisi B., Landini M.P. Enzyme-linked immunoadsorbent assay for the detection of cytomegalovirus IgM: comparison between eight commercial kits, immunofluorescence, and immunoblotting. J. Clin. Lab. Anal. 6:1992;216-218.
9. Lazzarotto T., Paya C.V., Smith T.F., Wiesner R.H., Krom R., Landini M.P. Antibody response to cytomegalovirus (CMV) polypeptides in liver transplant recipients with CMV hepatitis. Microbiologica. 15:1992;15-22.
10. Meyer H., Bankier A.T., Landini M.P., Brown C.M., Barrell B.G., Rüger B., Mach M. Identification and procaryotic expression of the gene coding for the highly immunogenic 28-kilodalton structural phosphoprotein (pp28) of human cytomegalovirus. J. Virol. 62:1988;2243-2250.
11. Plachter B., Wieczorek L., Scholl B.C., Ziegelmaier R., Jahn G. Detection of cytomegalovirus antibodies by an enzyme-linked immunosorbent assay using recombinant polypeptides of the large phosphorylated tegument protein pp150. J. Clin. Microbiol. 30:1992;201-206.
12. Ripalti A., Landini M.P., Mocarski E.S., La Placa M. Identification and preliminary use of recombinant lambda gt11 fusion proteins in cytomegalovirus diagnosis. J. Gen. Virol. 70:1989;1247-1251.
13. Scholl B.C., Von Hintzenstern J., Borish B., Traupe B., Broker M., Jahn G. Procaryotic expression of immunogenic polypeptides of the large phosphoprotein (pp150) of human cytomegalovirus. J. Gen. Virol. 69:1988;1195-1204.
14. Van Zanten J., Lazzarotto T., Campisi B., Vornhagen R., Jahn G., Landini M.P., The T.H. Comparative immunoblot analysis with ten different, partially overlapping recombinant fusion proteins derived from five different cytomegalovirus proteins. Microbiologica. 18:1995;223-228.
15. Vornhagen R., Hinderer W., Sonneborn H.H., Bein G., Matter L., The T.H., Jahn G., Plachter B. The DNA-binding protein pUL57 of human cytomegalovirus is a major target antigen for the immunoglobulin M antibody response during acute infection. J. Clin. Microbiol. 33:1995a;1927-1930.
16. Vornhagen R., Hinderer W., Plachter B., Jahn G., The T.H., Sonneborn H.H. Construction of recombinant autologous fusion protein which enables IgG-specific serodiagnosis of past HCMV infection. Biotest. Bull. 5:1995b;221-227.
17. Vornhagen R., Plachter B., Hinderer W., The T.H., Van Zanten J., Matter L., Schmidt C.A., Sonneborn H.H., Jahn G. Early serodiagnosis of acute human cytomegalovirus infection by enzyme-linked immunosorbent assay using recombinant antigens. J. Clin. Microbiol. 32:1994;981-986.
18. Weber B., Prosser F., Munkwitz A., Doerr H.W. Serological diagnosis of Cytomegalovirus infection: comparison of 8 enzyme immunoassays for the detection of HCMV specific IgM antibody. Clin. Diagn. Virol. 2:1994;245-259.
19. Weber B., Klinghardt U., Lux A., Rabenau H., Braun W., Doerr H.W. The detection of neutralizing antibodies against human cytomegalovirus is not influenced by strain heterogenicity. J. Med. Virol. 40:1993;28-34.